This book presents a detailed overview of the development of new viral vector-based vaccines before discussing two major applications: preventive vaccines for infectious diseases and therapeutic cancer vaccines. Viral vector-based vaccines hold a great potential for development into successful pharmaceutical products and several examples at the advanced pre-clinical or clinical stage are presented. Nevertheless, the most efforts were focused on novel and very innovative technologies for new generation of vector-based vaccines. Furthermore, specific topics such as delivery and adjuvant and protection strategies for cell-mediated-based vaccines are presented. Given its scope, the book is a amust reada for all those involved in vaccine development, both in academia and industrial vaccine development.... h7n9/ChinaH7N9JointMissionReport2013.pdf Cobbin JC, Verity EE, Gilbertson BP, Rockman SP, Brown LE (2013) The source ... J Virol 87:5577a5585 Cornelissen LA, de Leeuw OS, Tacken MG, Klos HC, de Vries RP, de Boer- Luijtze EA, van Zoelen-Bos ... J Clin Invest 120:1663a1673 Corti D, Voss J, Gamblin SJ, Codoni G, Macagno A, Jarrossay D, Vachieri SG, Pinna D, Minola A, ... Influenza Other Respir Viruses 3:107a117 Dawood FS, Iuliano AD, Reed C, Meltzer MI, Shay DKanbsp;...
|Title||:||Novel Technologies for Vaccine Development|
|Author||:||Igor Lukashevich, Haval Shirwan|
|Publisher||:||Springer - 2014-11-13|